Cargando…

Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer

BACKGROUND: Non-muscular invasive bladder cancer (NMIBC) has a high risk of recurrence. As androgen receptor (AR) reportedly affects bladder cancer, we assessed the correlation between NMIBC recurrence and tumor AR expression in Japanese patients. METHODS: We retrospectively reviewed 53 specimens of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yasui, Masato, Kawahara, Takashi, Izumi, Koji, Yao, Masahiro, Ishiguro, Yukari, Ishiguro, Hitoshi, Uemura, Hiroji, Miyoshi, Yasuhide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454612/ https://www.ncbi.nlm.nih.gov/pubmed/30961575 http://dx.doi.org/10.1186/s12885-019-5512-9

Ejemplares similares

Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence
por: Izumi, Koji, et al.
Publicado: (2016)

Expression of PD‐L1 and CTLA‐4 in female urethral carcinoma
por: Ninomiya, Sahoko, et al.
Publicado: (2018)

A retrospective study on the possible systematic inflammatory response markers to predict the prognosis of patients with bladder cancer undergoing radial cystectomy
por: Ninomiya, Sahoko, et al.
Publicado: (2020)

A high serum dehydroepiandrosterone concentration is a predictor of candidates for active surveillance in men with serum prostate-specific antigen < 10 ng/mL
por: Miyoshi, Yasuhide, et al.
Publicado: (2022)

Inserting a Metallic Ureteral Stent Using an Antegrade Approach Freed a Patient from Nephrostomy Created due to Hydronephrosis Caused by Bladder Cancer
por: Kawahara, Takashi, et al.
Publicado: (2019)

Functional paraganglioma of the bladder: Both radiographic‐negative and laboratory‐negative case
por: Sugimura, Rumiko, et al.
Publicado: (2019)

PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2018)

Androgen deprivation therapy prevents bladder cancer recurrence
por: Izumi, Koji, et al.
Publicado: (2014)

A lower psoas muscle index predicts a poorer prognosis in metastatic hormone‐naïve prostate cancer
por: Iwamoto, Genta, et al.
Publicado: (2020)

The Achievement of Long-Term CRPC Control in a Patient with Enzalutamide-Induced Nausea and Fatigue after Overcoming the Adverse Events with a Temporary Drug Holiday
por: Kawahara, Takashi, et al.
Publicado: (2019)

Clinical outcome of surgical management for symptomatic metastatic spinal cord compression from prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2020)

Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
por: Kawahara, Takashi, et al.
Publicado: (2019)

Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide
por: Kumano, Yohei, et al.
Publicado: (2019)

Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer
por: Kawahara, Takashi, et al.
Publicado: (2016)

Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade
por: Yokomizo, Yumiko, et al.
Publicado: (2016)

A novel prediction model for the completion of six cycles of radium-223 treatment and survival in patients with metastatic castration-resistant prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2021)

Prognosis and safety of radium‐223 with concurrent abiraterone acetate or enzalutamide use for metastatic castration‐resistant prostate cancer: Real‐world data of Japanese patients
por: Miyoshi, Yasuhide, et al.
Publicado: (2020)

Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium‐223
por: Miyoshi, Yasuhide, et al.
Publicado: (2020)

Changing the enzalutamide form from a capsule to a tablet improves the adherence of medicine intake: A case of a significant decrease in the prostate‐specific antigen level and improvement in radiographic findings
por: Kawahara, Takashi, et al.
Publicado: (2019)

Longer Control of Nivolumab in Metastatic Renal Cell Carcinoma Patients with End-Stage Kidney Disease on Dialysis
por: Morinaga, Ryota, et al.
Publicado: (2019)

Successful Resection of Cisplatin-Resistant Renal Pelvic Cancer after the Administration of Pembrolizumab as Second-Line Therapy
por: Kawahara, Takashi, et al.
Publicado: (2019)

Clear cell adenocarcinoma of the prostatic urethra: A case report
por: Sugimura, Rumiko, et al.
Publicado: (2018)

Paraganglioma in the bladder: a case report
por: Iwamoto, Genta, et al.
Publicado: (2017)

A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control
por: Sugimura, Rumiko, et al.
Publicado: (2019)

The neutrophil-to-lymphocyte ratio at the prostate-specific antigen nadir predicts the time to castration-resistant prostate cancer
por: Iwamoto, Genta, et al.
Publicado: (2021)

Lack of an association between the aPKCλ/ι expression in prostate cancer and the patient outcomes
por: Yokomizo, Yumiko, et al.
Publicado: (2017)

Successful treatment with sorafenib for sunitinib‐refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib
por: Morinaga, Ryota, et al.
Publicado: (2018)

Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy
por: Kawahara, Takashi, et al.
Publicado: (2016)

Foreign body in the bladder: A case report
por: Shimokihara, Kota, et al.
Publicado: (2017)

Chemopreventive effects of angiotensin II receptor type 2 agonist on prostate carcinogenesis by the down-regulation of the androgen receptor
por: Ito, Yusuke, et al.
Publicado: (2018)

Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib
por: Kawahara, Takashi, et al.
Publicado: (2019)

Preference for enzalutamide capsules versus tablet pills in patients with prostate cancer
por: Ninomiya, Sahoko, et al.
Publicado: (2019)

Impact of smoking habit on overactive bladder symptoms and incontinence in women
por: Kawahara, Takashi, et al.
Publicado: (2020)

Port site recurrence after laparoscopic radical nephrectomy: a case report
por: Shimokihara, Kota, et al.
Publicado: (2017)

Sperm cryopreservation before definitive therapy for early‐stage prostate cancer: A single institution experience
por: Miyoshi, Yasuhide, et al.
Publicado: (2022)

ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion
por: Kawahara, Takashi, et al.
Publicado: (2016)

A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy
por: Kasahara, Ryo, et al.
Publicado: (2017)

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Inflammatory Myofibroblastic Tumor in the Bladder: A Case Report
por: Kondo, Takuya, et al.
Publicado: (2016)

Sarcomatoid Variant of Bladder Carcinoma: A Case Report
por: Uemura, Koichi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i956ckouijv2i4ctt8t2a9pdq0